Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease

Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease

Aging is by far the most prominent risk factor for Alzheimer's disease (AD), and both aging and AD are associated with apparent metabolic alterations. As developing effective therapeutic interventions to treat AD is clearly in urgent need, the impact of modulating whole-body and intracellular m...

Full description

Saved in:
Bibliographic Details
Main Authors: Steven N. Austad (Author), Scott Ballinger (Author), Thomas W. Buford (Author), Christy S. Carter (Author), Daniel L. Smith, Jr (Author), Victor Darley-Usmar (Author), Jianhua Zhang (Author)
Format: Book
Published: Elsevier, 2022-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items